Vytorin researchers call for new data-release rules

Prompted by Merck and Schering-Plough's early release of the SEAS study data on Vytorin, Duke University researchers are calling for new rules governing the release of trial data; they'd invest third parties with more power to monitor research as it's going on and guard data once it's generated. Report

Suggested Articles

Patients with epithelioid sarcoma previously had no targeted treatment options, but that'll change with Epizyme's approval for Tazverik.

With federal prosecutors laying waste to Insys' executive team, one big domino was still left to fall: Founder and former CEO John Kapoor.

Amgen buys out Astellas Japanese joint venture. Sun Piaoyang steps down as Hengrui chairman. Moderna-NIH and Inovio work on coronavirus vaccines.